abstract |
Disclosed are binding IL-2 receptor βγc heterodimer (IL- 2Rβγc ), IL-4 receptor αγc heterodimer (IL- 4Rαγc ), or IL-13 receptor α subunit (IL-13 receptor α subunit (IL-4Rαγc) -13Rα) de novo designed polypeptides, and methods for using and designing the same. |